This extensive network of interactions between IGF1, ER, and HER2 signaling pathways, and potential heterogeneity of risk by tumor subtype for IGF1 genes observed in our study suggest greater complexities in the relationship between IGF1 pathway genes and breast cancer etiology. Here, ERBB2 is linked to breast carcinoma.